AP NEWS

T-Cell Immunotherapy Markets to 2024: Lucrative Opportunities from Rapidly Increasing R&D Activities - ResearchAndMarkets.com

November 6, 2018

DUBLIN--(BUSINESS WIRE)--Nov 6, 2018--The “T-Cell Immunotherapy Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering.

The report predicts the global t-cell immunotherapy market to grow with a healthy CAGR over the forecast period of 2018-2024. The study on t-cell immunotherapy market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

Market Dynamics

Drivers

Growing Occurrence of Cancer in both Children as well as in AdultsOn-Going Development to Improve Existing Therapies

Restraints

Neurological Problems Associated with T-cell Immunotherapy

Opportunities

Rapidly Increasing Research & Development ActivitiesTechnological Advancement in Cancer Treatment

Segments Covered

Mechanism of Action

Active ImmunotherapyPassive Immunotherapy

Type of Therapy

CAR-TTCRTIL

Product Class

Monoclonal AntibodiesOncolytic Virus TherapyBispecific AntibodiesCytokines

Companies Profiled

Adaptimmune TherapeuticsBluebird BioInnovative Cellular TherapeuticsNovartisSinobioway Cell TherapyCellectisCARsgen TherapeuticsAutolusCelgene

Key Topics Covered

1. Preface

2. Executive Summary

3. Global T-Cell Immunotherapy Market Overview

4. T-Cell Immunotherapy Market Macro Indicator Analysis

5. Global T-Cell Immunotherapy Market by Mechanism of Action

6. Global T-Cell Immunotherapy Market by Type of Therapy

7. Global T-Cell Immunotherapy Market by Product Class

8. Global T-Cell Immunotherapy Market by Region

9. Company Profiles and Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/9dfcs5/tcell?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181106005556/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/06/2018 08:51 AM/DISC: 11/06/2018 08:51 AM

http://www.businesswire.com/news/home/20181106005556/en

AP RADIO
Update hourly